ScripsAmerica Inc. (SCRCQ)

[coolerheadsprevail]

Scripsamerica Presentation at today's Conference! Go SCRC! Tut

www.snl.com/Cache/1001198579.PDF?O=PDF...

This presentation actually doesn't look that bad. Each one is getting better looking than the one before. That being said, the market needs to see actual results that substantiate all these continuous rose-colored forward-looking statements.

I actually don't have much hope for RapiMed -- not so much whether it will be launched, because it very well may, but rather I am not convinced that it is a novel enough product that can capture meaningful market share in China/HK, the US, or any other country.

Of all the potential new business segments outlined in the presentation deck, the most promising, IMO, is the Physician Dispensing Program. If (1) The margin on the original purchase from PIMD truly turns out to be what is claimed in the presentation, AND (2) The profit-sharing on the markup at the physician level is what is claimed in the presentation, AND (3) The number of enrolled physicians hits the goal by 12/31/15, AND (4) The Rx volume per physician is as high as it is claimed in the presenation... ...then this can contribute 4.1 cents/share to EPS (3.3 cents/share fully-diluted), which would be very good by year-end, which is only 7 months away.

Note that the revenue numbers being projected aren't all that high for this physician dispensing program relative to what we have previously seen for Main Ave... ...it is because, as I've been saying, revenues don't mean squat -- it's ALL about earnings.

Main Ave had record-setting revenues and approved orders running at a $64M annual rate in Q4'14 but still lost money, so that is a textbook example of why the market has turned its back on SCRC.

SCRC needs to show the market that it can control its reckless spending and behave in a fiduciarily responsible manner. And as much as SCRC's paid criminal homophobic consultant/promoter JOSEPH ZAMPETTI continues to smear SCRC's reputation by opening his piehole and trying to tell retail suckers that the missing SEC filings aren't important, the truth of the matter is that SEC filings ARE very important for ALL public companies to file and get out to the marketplace.

Without the SEC filings, the market has zero confidence in SCRC's ability to operate profitably -- and by now, the market has seen enough of BS Schneiderman's BS to no longer trust simply his word that he has implemented cost savings. The market needs to see the savings in the form of audited financial statements showing hefty net profits. Once we see these, then the buying will return.

The problem is that so long as SCRC continues to have no actual meaningful results to show, but only has forward-looking statements of all the grand markets it plans to enter, then this only delays when the market will be able to see SEC filings that can prove that SCRC is actually executing its business model. Enough talk. SCRC needs to deliver...